Maxi Investments CY Ltd Grows Position in Intuitive Surgical, Inc. $ISRG

Maxi Investments CY Ltd increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 45.2% in the fourth quarter, Holdings Channel reports. The firm owned 8,145 shares of the medical equipment provider’s stock after buying an additional 2,535 shares during the period. Maxi Investments CY Ltd’s holdings in Intuitive Surgical were worth $4,613,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Riversedge Advisors LLC boosted its stake in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after buying an additional 17 shares during the period. Fiduciary Financial Group LLC raised its stake in shares of Intuitive Surgical by 2.1% in the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after acquiring an additional 19 shares during the period. Prosperity Consulting Group LLC lifted its holdings in shares of Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after acquiring an additional 19 shares during the last quarter. Rossmore Private Capital lifted its holdings in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after acquiring an additional 20 shares during the last quarter. Finally, Activest Wealth Management boosted its position in shares of Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG opened at $453.49 on Friday. The business has a fifty day moving average price of $472.19 and a 200 day moving average price of $517.39. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The stock has a market capitalization of $160.61 billion, a price-to-earnings ratio of 54.97, a PEG ratio of 3.61 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the business posted $1.81 EPS. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on ISRG shares. Leerink Partners dropped their target price on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Truist Financial lowered their price target on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Raymond James Financial dropped their price objective on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group cut their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a report on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. decreased their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $581.91.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 421 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at approximately $202,438.64. This represents a 50.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 5,906 shares of company stock valued at $2,907,726 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.